Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Mogamulizumab versus investigator choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma.

Phillips AA, Fields PA, Hermine O, Ramos JC, Beltran BE, Pereira J, Wandroo F, Feldman T, Taylor GP, Sawas A, Humphrey J, Kurman M, Moriya J, Dwyer K, Leoni M, Conlon K, Cook L, Gonsky J, Horwitz SM.

Haematologica. 2018 Dec 20. pii: haematol.2018.205096. doi: 10.3324/haematol.2018.205096. [Epub ahead of print]

2.

Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping.

Kagdi HH, Demontis MA, Fields PA, Ramos JC, Bangham CR, Taylor GP.

Cancer Med. 2017 Jan;6(1):298-309. doi: 10.1002/cam4.928. Epub 2016 Dec 30.

3.

Rapid proteomic responses to a near-lethal heat stress in the salt marsh mussel Geukensia demissa.

Fields PA, Burmester EM, Cox KM, Karch KR.

J Exp Biol. 2016 Sep 1;219(Pt 17):2673-86. doi: 10.1242/jeb.141176. Epub 2016 Jun 22.

4.

Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL.

Mikhaeel NG, Smith D, Dunn JT, Phillips M, Møller H, Fields PA, Wrench D, Barrington SF.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1209-19. doi: 10.1007/s00259-016-3315-7. Epub 2016 Feb 23.

5.

H2A.Z.1 Monoubiquitylation Antagonizes BRD2 to Maintain Poised Chromatin in ESCs.

Surface LE, Fields PA, Subramanian V, Behmer R, Udeshi N, Peach SE, Carr SA, Jaffe JD, Boyer LA.

Cell Rep. 2016 Feb 9;14(5):1142-1155. doi: 10.1016/j.celrep.2015.12.100. Epub 2016 Jan 21.

6.

Adaptations of protein structure and function to temperature: there is more than one way to 'skin a cat'.

Fields PA, Dong Y, Meng X, Somero GN.

J Exp Biol. 2015 Jun;218(Pt 12):1801-11. doi: 10.1242/jeb.114298. Review.

7.

Assessing risk and improving survival in lymphoma.

Fields PA, Wrench DJ.

Br J Gen Pract. 2015 May;65(634):220-1. doi: 10.3399/bjgp15X684661. No abstract available.

8.

H2A.Z: a molecular rheostat for transcriptional control.

Subramanian V, Fields PA, Boyer LA.

F1000Prime Rep. 2015 Jan 5;7:01. doi: 10.12703/P7-01. eCollection 2015. Review.

9.

High-pressure-low-temperature cryostat designed for use with fourier transform infrared spectrometers and time-resolved infrared spectroscopy.

Calladine JA, Love A, Fields PA, Wilson RG, George MW.

Appl Spectrosc. 2014;68(3):324-31. doi: 10.1366/13-07270.

PMID:
24666949
10.

Changes in protein expression in the salt marsh mussel Geukensia demissa: evidence for a shift from anaerobic to aerobic metabolism during prolonged aerial exposure.

Fields PA, Eurich C, Gao WL, Cela B.

J Exp Biol. 2014 May 1;217(Pt 9):1601-12. doi: 10.1242/jeb.101758. Epub 2014 Feb 5.

11.

De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trial.

Fields PA, Townsend W, Webb A, Counsell N, Pocock C, Smith P, Jack A, El-Mehidi N, Johnson PW, Radford J, Linch DC, Cunnningham D.

J Clin Oncol. 2014 Feb 1;32(4):282-7. doi: 10.1200/JCO.2013.49.7586. Epub 2013 Nov 12. Erratum in: J Clin Oncol. 2014 Oct 20;32(30):3461.

PMID:
24220559
12.

Diagnosis and subtyping of de novo and relapsed mediastinal lymphomas by endobronchial ultrasound needle aspiration.

Moonim MT, Breen R, Fields PA, Santis G.

Am J Respir Crit Care Med. 2013 Nov 15;188(10):1216-23. doi: 10.1164/rccm.201303-0462OC.

13.

H2A.Z acidic patch couples chromatin dynamics to regulation of gene expression programs during ESC differentiation.

Subramanian V, Mazumder A, Surface LE, Butty VL, Fields PA, Alwan A, Torrey L, Thai KK, Levine SS, Bathe M, Boyer LA.

PLoS Genet. 2013;9(8):e1003725. doi: 10.1371/journal.pgen.1003725. Epub 2013 Aug 22.

14.

A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.

Benton EC, Crichton S, Talpur R, Agar NS, Fields PA, Wedgeworth E, Mitchell TJ, Cox M, Ferreira S, Liu P, Robson A, Calonje E, Stefanato CM, Wilkins B, Scarisbrick J, Wain EM, Child F, Morris S, Duvic M, Whittaker SJ.

Eur J Cancer. 2013 Sep;49(13):2859-68. doi: 10.1016/j.ejca.2013.04.018. Epub 2013 Jun 1.

PMID:
23735705
15.

Coping with thermal challenges: physiological adaptations to environmental temperatures.

Tattersall GJ, Sinclair BJ, Withers PC, Fields PA, Seebacher F, Cooper CE, Maloney SK.

Compr Physiol. 2012 Jul;2(3):2151-202. doi: 10.1002/cphy.c110055. Review.

PMID:
23723035
16.

Braveheart, a long noncoding RNA required for cardiovascular lineage commitment.

Klattenhoff CA, Scheuermann JC, Surface LE, Bradley RK, Fields PA, Steinhauser ML, Ding H, Butty VL, Torrey L, Haas S, Abo R, Tabebordbar M, Lee RT, Burge CB, Boyer LA.

Cell. 2013 Jan 31;152(3):570-83. doi: 10.1016/j.cell.2013.01.003. Epub 2013 Jan 24.

17.

"Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).

Fields PA, Taylor GP.

Curr Hematol Malig Rep. 2012 Dec;7(4):267-75. doi: 10.1007/s11899-012-0139-9. Review.

PMID:
23093306
18.

Pre-morbid human T-lymphotropic virus type I proviral load, rather than percentage of abnormal lymphocytes, is associated with an increased risk of aggressive adult T-cell leukemia/lymphoma.

Hodson A, Laydon DJ, Bain BJ, Fields PA, Taylor GP.

Haematologica. 2013 Mar;98(3):385-8. doi: 10.3324/haematol.2012.069476. Epub 2012 Aug 8.

19.

Latitudinal variation in protein expression after heat stress in the salt marsh mussel Geukensia demissa.

Fields PA, Cox KM, Karch KR.

Integr Comp Biol. 2012 Nov;52(5):636-47. doi: 10.1093/icb/ics086. Epub 2012 May 28.

PMID:
22641835
20.

Treatment of the elderly patient with diffuse large B cell lymphoma.

Fields PA, Linch DC.

Br J Haematol. 2012 Apr;157(2):159-70. doi: 10.1111/j.1365-2141.2011.09011.x. Epub 2012 Jan 16. Review.

PMID:
22463486
21.

Proteomic responses of blue mussel (Mytilus) congeners to temperature acclimation.

Fields PA, Zuzow MJ, Tomanek L.

J Exp Biol. 2012 Apr 1;215(Pt 7):1106-16. doi: 10.1242/jeb.062273.

22.

Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.

Hodson A, Crichton S, Montoto S, Mir N, Matutes E, Cwynarski K, Kumaran T, Ardeshna KM, Pagliuca A, Taylor GP, Fields PA.

J Clin Oncol. 2011 Dec 10;29(35):4696-701. doi: 10.1200/JCO.2011.35.5578. Epub 2011 Oct 31.

23.

Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.

Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ.

J Clin Oncol. 2010 Nov 1;28(31):4730-9. doi: 10.1200/JCO.2009.27.7665. Epub 2010 Sep 20.

PMID:
20855822
24.

Thyroid lymphoma and airway obstruction - is there a rationale for surgical management?

Joshi A, Chan J, Bruch G, Jeannon JP, Mikhaeel NG, Fields PA, Simo R.

Int J Clin Pract. 2009 Nov;63(11):1647-52. doi: 10.1111/j.1742-1241.2009.02050.x.

PMID:
19832821
25.

Management of lymphoma in pregnancy.

Hodby K, Fields PA.

Obstet Med. 2009 Jun;2(2):46-51. doi: 10.1258/om.2009.090007. Epub 2009 May 22. Review. Erratum in: Obstet Med. 2009 Sep;2(3):131.

26.

Diverse hematopoietic potentials of five human embryonic stem cell lines.

Chang KH, Nelson AM, Fields PA, Hesson JL, Ulyanova T, Cao H, Nakamoto B, Ware CB, Papayannopoulou T.

Exp Cell Res. 2008 Oct 1;314(16):2930-40. doi: 10.1016/j.yexcr.2008.07.019. Epub 2008 Jul 29.

27.

Function of muscle-type lactate dehydrogenase and citrate synthase of the Galápagos marine iguana, Amblyrhynchus cristatus, in relation to temperature.

Fields PA, Strothers CM, Mitchell MA.

Comp Biochem Physiol B Biochem Mol Biol. 2008 May;150(1):62-73. doi: 10.1016/j.cbpb.2008.01.008. Epub 2008 Feb 9.

PMID:
18313960
28.

Sublethal exposure to UV radiation affects respiration rates of the freshwater cladoceran Daphnia catawba.

Fischer JM, Fields PA, Pryzbylkowski PG, Nicolai JL, Neale PJ.

Photochem Photobiol. 2006 Mar-Apr;82(2):547-50.

PMID:
16613511
29.
31.

The prognostic value of interim positron emission tomography scans combined with immunohistochemical data in diffuse large B-cell lymphoma.

Fields PA, Mikhaeel G, Hutchings M, van der Walt J, Nunan T, Schey SA.

Haematologica. 2005 Dec;90(12):1711-3.

32.

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

Mikhaeel NG, Hutchings M, Fields PA, O'Doherty MJ, Timothy AR.

Ann Oncol. 2005 Sep;16(9):1514-23. Epub 2005 Jun 24.

PMID:
15980161
33.

Immunohistochemical localization of relaxin-like factor/insulin-like peptide-3 in the bovine corpus luteum.

Nichols N, Binta H, Fields PA, Drost M, Chang SM, Ivell R, Fields MJ.

Ann N Y Acad Sci. 2005 May;1041:506-9.

PMID:
15956752
34.

Clinical use of relaxin to facilitate birth: reasons for investigating the premise.

Lee HY, Zhao S, Fields PA, Sherwood OD.

Ann N Y Acad Sci. 2005 May;1041:351-66.

PMID:
15956733
35.

Is relaxin a calcium transporter/buffer?

Fields PA.

Ann N Y Acad Sci. 2005 May;1041:328-31.

PMID:
15956729
36.

Potential binding sites for relaxin in pregnant rabbits.

Fields PA, Fields MJ.

Ann N Y Acad Sci. 2005 May;1041:123-5.

PMID:
15956695
37.

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR.

Ann Oncol. 2005 Jul;16(7):1160-8. Epub 2005 Jun 6.

PMID:
15939713
38.
40.

Splenunculectomy in autoimmune thrombocytopenic purpura.

Fields PA, Cohen H, Patterson KG.

Br J Haematol. 2003 Nov;123(3):377. No abstract available.

PMID:
14616992
41.

Localization of the iron transport proteins Mobilferrin and DMT-1 in the duodenum: the surprising role of mucin.

Simovich M, Hainsworth LN, Fields PA, Umbreit JN, Conrad ME.

Am J Hematol. 2003 Sep;74(1):32-45.

42.

Non-Hodgkin's lymphomas: clinical governance issues.

Fields PA, Goldstone AH.

Best Pract Res Clin Haematol. 2002 Sep;15(3):577-96. Review.

PMID:
12468407
43.

Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy.

Herzog RW, Fields PA, Arruda VR, Brubaker JO, Armstrong E, McClintock D, Bellinger DA, Couto LB, Nichols TC, High KA.

Hum Gene Ther. 2002 Jul 20;13(11):1281-91.

PMID:
12162811
44.
45.

Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males.

Arruda VR, Fields PA, Milner R, Wainwright L, De Miguel MP, Donovan PJ, Herzog RW, Nichols TC, Biegel JA, Razavi M, Dake M, Huff D, Flake AW, Couto L, Kay MA, High KA.

Mol Ther. 2001 Dec;4(6):586-92.

46.
47.

Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9.

Fields PA, Arruda VR, Armstrong E, Chu K, Mingozzi F, Hagstrom JN, Herzog RW, High KA.

Mol Ther. 2001 Sep;4(3):201-10.

49.

Review: Protein function at thermal extremes: balancing stability and flexibility.

Fields PA.

Comp Biochem Physiol A Mol Integr Physiol. 2001 Jun;129(2-3):417-31. Review.

PMID:
11423314
50.

Supplemental Content

Loading ...
Support Center